📊 TNONW Key Takeaways
Is Tenon Medical, Inc. (TNONW) a Good Investment?
Tenon Medical is an early-stage surgical device company with promising 20.4% revenue growth and healthy 59.8% gross margins, indicating product-market fit. However, the company is burning $10.7M annually in operating cash flow against only $3.9M in revenue, with approximately 4 months of cash runway at current burn rates. Without rapid revenue acceleration, significant cost reduction, or emergency financing, the company faces severe solvency risk.
Why Buy Tenon Medical, Inc. Stock? TNONW Key Strengths
- Strong gross margin of 59.8% indicates strong product value and pricing power
- Revenue growing 20.4% YoY demonstrates market demand for surgical devices
- Debt-free balance sheet with no long-term debt obligations
- Adequate short-term liquidity with 2.11x current ratio and 1.78x quick ratio
- Net loss improving 8.2% YoY shows operational efficiency gains
TNONW Stock Risks: Tenon Medical, Inc. Investment Risks
- Severe cash burn of $10.7M annually against $3.9M revenue creates ~4 month runway with current $3.8M cash reserves
- Operating margin of -324.3% indicates operating expenses 13x revenue, unsustainable even for early-stage companies
- Free cash flow of -$11.0M compounds liquidity crisis and limits ability to fund operations without external capital
- Negative ROE (-249.1%) and ROA (-116.7%) indicate extremely poor capital efficiency and asset utilization
- High dilution risk from required future financing at distressed valuations
Key Metrics to Watch
- Quarterly revenue trajectory and acceleration toward gross profit breakeven
- Operating cash burn rate and monthly cash consumption trends
- Gross margin sustainability as volume scales
- Cash balance depletion timeline and financing announcements
- Operating expense reduction or revenue inflection required for survival
Tenon Medical, Inc. (TNONW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.11x current ratio provides a solid financial cushion.
TNONW Profit Margin, ROE & Profitability Analysis
TNONW vs Healthcare Sector: How Tenon Medical, Inc. Compares
How Tenon Medical, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Tenon Medical, Inc. Stock Overvalued? TNONW Valuation Analysis 2026
Based on fundamental analysis, Tenon Medical, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Tenon Medical, Inc. Balance Sheet: TNONW Debt, Cash & Liquidity
TNONW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Tenon Medical, Inc.'s revenue has grown significantly by 471% over the 5-year period, indicating strong business expansion. The most recent EPS of $-11.26 indicates the company is currently unprofitable.
TNONW Revenue Growth, EPS Growth & YoY Performance
TNONW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $887.0K | -$3.2M | $-0.40 |
| Q2 2025 | $564.0K | -$2.8M | $-0.36 |
| Q1 2025 | $719.0K | -$3.6M | $-1.01 |
| Q3 2024 | $887.0K | -$3.2M | $-3.63 |
| Q2 2024 | $743.0K | -$3.8M | $-1.02 |
| Q1 2024 | $433.0K | -$3.6M | $-1.25 |
| Q3 2023 | $208.0K | -$3.2M | $-1.46 |
| Q2 2023 | $135.0K | -$4.3M | $-0.33 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Tenon Medical, Inc. Dividends, Buybacks & Capital Allocation
TNONW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Tenon Medical, Inc. (CIK: 0001560293)
📋 Recent SEC Filings
❓ Frequently Asked Questions about TNONW
What is the AI rating for TNONW?
Tenon Medical, Inc. (TNONW) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are TNONW's key strengths?
Claude: Strong gross margin of 59.8% indicates strong product value and pricing power. Revenue growing 20.4% YoY demonstrates market demand for surgical devices.
What are the risks of investing in TNONW?
Claude: Severe cash burn of $10.7M annually against $3.9M revenue creates ~4 month runway with current $3.8M cash reserves. Operating margin of -324.3% indicates operating expenses 13x revenue, unsustainable even for early-stage companies.
What is TNONW's revenue and growth?
Tenon Medical, Inc. reported revenue of $3.9M.
Does TNONW pay dividends?
Tenon Medical, Inc. does not currently pay dividends.
Where can I find TNONW SEC filings?
Official SEC filings for Tenon Medical, Inc. (CIK: 0001560293) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is TNONW's EPS?
Tenon Medical, Inc. has a diluted EPS of $-1.70.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is TNONW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Tenon Medical, Inc. has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is TNONW stock overvalued or undervalued?
Valuation metrics for TNONW: ROE of -249.1% (sector avg: 15%), net margin of -318.4% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy TNONW stock in 2026?
Our dual AI analysis gives Tenon Medical, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is TNONW's free cash flow?
Tenon Medical, Inc.'s operating cash flow is $-10.7M, with capital expenditures of $273.0K. FCF margin is -279.4%.
How does TNONW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -318.4% (avg: 12%), ROE -249.1% (avg: 15%), current ratio 2.11 (avg: 2).